Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Second Primary × Temozolomide × 1 year × Clear all

Sponsor

Conditions

Glioblastoma 93 Glioma 36 Brain Neoplasms 21 Neuroblastoma 20 Gliosarcoma 15 Astrocytoma 15 Sarcoma, Ewing 12 Rhabdomyosarcoma 11 Recurrence 10 Medulloblastoma 10 Small Cell Lung Carcinoma 7 Sarcoma 7 Neoplasms 7 Oligodendroglioma 6 Melanoma 6 Ependymoma 6 Diffuse Intrinsic Pontine Glioma 6 Osteosarcoma 5 Prostatic Neoplasms 4 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Lymphoma, Follicular 3 Lymphoma 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Adenoma, Islet Cell 3 Wilms Tumor 2 Somatostatinoma 2 Rhabdoid Tumor 2

Interventions

avelumab 1 Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Registries 1 Probiotics 1 Patient Reported Outcome Measures 1 Nicotine Chewing Gum 1 Leucovorin 1 Lenalidomide 1 Irinotecan 1 Interviews as Topic 1 Fluorouracil 1 Cisplatin 1 Cetuximab 1 Bupropion 1 Bleomycin 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡